Latest News and Press Releases

First quarter revenue of $24.4M, +46% year-over-year growth; IFRS gross margin of 75.0%First quarter usage fee revenue of $11.0M, +56% year-over-year growth IFRS and non-IFRS net income of $1.3M...

Record quarterly revenue in fourth quarter of $28.9M, +58% year-over-year growth; IFRS gross margin of 75.6% Fourth quarter pulse recurring revenue of $13.2M, +83% year-over-year growthFull fiscal...

SAN CLEMENTE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide,...

—  Record quarterly revenue in third quarter of $21.1M, +56% year-over-year growth; IFRS gross margin of 73.7%  — Third quarter pulse recurring revenue of $8.3M, +55% year-over-year growth —...

SAN CLEMENTE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced...

SAN CLEMENTE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced...

The Pure Impact VIP™ standalone device represents a major extension of the Pure Impact™ product line and introduces an all-in-one independent unitStandalone device is launched with an enhanced Pure...

SAN CLEMENTE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners...

• Quarterly record revenue in Q2 of $21M, +43% year-over-year growth; IFRS gross margin of 75.5% • Second quarter pulse recurring revenue of $9.2M, +53% year-over-year growth • First half revenue of...

SAN CLEMENTE, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW),  an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners...